A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis

Abstract Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. Most studies evaluated the post-alteplase haemorrhagic transformation of brain infar...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed G. Zeinhom, Sherihan Rezk Ahmed, Ahmed Mohamed Kohail, Islam Fathallah Mohamed Kamel, ALshimaa Mahfouz Abdelrahman, Omar M. AL-Nozha, Mohamed Almoataz, Tarek Youssif Omar Youssif, Ahmed Mohamed Ali Daabis, Hossam Mohamed Refat, Ahmed Ahmed Mohamed Kamal Ebied, Ahmed Elbassiouny, Ahmed Zaki Omar Akl, Ashfaq Shuaib, Mohamed Ismaiel, Asmaa Ibrahem Desouky Mostafa Ibrahem, Mohamed Fouad Elsayed Khalil
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-76189-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147839914147840
author Mohamed G. Zeinhom
Sherihan Rezk Ahmed
Ahmed Mohamed Kohail
Islam Fathallah Mohamed Kamel
ALshimaa Mahfouz Abdelrahman
Omar M. AL-Nozha
Mohamed Almoataz
Tarek Youssif Omar Youssif
Ahmed Mohamed Ali Daabis
Hossam Mohamed Refat
Ahmed Ahmed Mohamed Kamal Ebied
Ahmed Elbassiouny
Ahmed Zaki Omar Akl
Ashfaq Shuaib
Mohamed Ismaiel
Asmaa Ibrahem Desouky Mostafa Ibrahem
Mohamed Fouad Elsayed Khalil
author_facet Mohamed G. Zeinhom
Sherihan Rezk Ahmed
Ahmed Mohamed Kohail
Islam Fathallah Mohamed Kamel
ALshimaa Mahfouz Abdelrahman
Omar M. AL-Nozha
Mohamed Almoataz
Tarek Youssif Omar Youssif
Ahmed Mohamed Ali Daabis
Hossam Mohamed Refat
Ahmed Ahmed Mohamed Kamal Ebied
Ahmed Elbassiouny
Ahmed Zaki Omar Akl
Ashfaq Shuaib
Mohamed Ismaiel
Asmaa Ibrahem Desouky Mostafa Ibrahem
Mohamed Fouad Elsayed Khalil
author_sort Mohamed G. Zeinhom
collection DOAJ
description Abstract Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. Most studies evaluated the post-alteplase haemorrhagic transformation of brain infarction as a homogeneous entity but we evaluated the predictors of each subtype of haemorrhagic transformation of brain infarction. Our trial included 616 AIS alteplase-treated patients. We evaluated the ability of different risk factors, clinical presentation, and imaging features to predict different haemorrhagic transformation (HT) subtypes. HT was seen in 152 patients (24.7%), higher NIHSS, cardioembolic stroke and atrial fibrillation were independent predictors of all ECASS-based subtypes of hemorrhagic infarction, in addition, anterior-circulation stroke was an independent predictor of hemorrhagic infarction type 1 (odds ratio [OR], 11.04; 95% CI, 9.81 to 12.70; P-value > 0.001) and type2 (OR, 11.89; 95% CI, 9.79 to 14.44; P-value > 0.001), while older age was also an independent predictor of parenchymal hematoma type1 (OR, 1.312; 95% CI, 1.245 to 1.912; P-value 0.02). In AIS patients treated with alteplase in Egypt and Saudi Arabia, higher NIHSS, cardioembolic stroke and atrial fibrillation were independent predictors of all ECASS-based subtypes of hemorrhagic infarction; in addition, anterior-circulation stroke was an independent predictor of hemorrhagic infarction type 1 and 2, while older age was also an independent predictor of parenchymal hematoma type1. Trial registration: (clinicaltrials.gov NCT06337175), retrospectively registered on 29/03/2024.
format Article
id doaj-art-c057e650ba9849e8ae73d3a2ebf5703c
institution Kabale University
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-c057e650ba9849e8ae73d3a2ebf5703c2024-12-01T12:25:51ZengNature PortfolioScientific Reports2045-23222024-11-0114111310.1038/s41598-024-76189-0A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysisMohamed G. Zeinhom0Sherihan Rezk Ahmed1Ahmed Mohamed Kohail2Islam Fathallah Mohamed Kamel3ALshimaa Mahfouz Abdelrahman4Omar M. AL-Nozha5Mohamed Almoataz6Tarek Youssif Omar Youssif7Ahmed Mohamed Ali Daabis8Hossam Mohamed Refat9Ahmed Ahmed Mohamed Kamal Ebied10Ahmed Elbassiouny11Ahmed Zaki Omar Akl12Ashfaq Shuaib13Mohamed Ismaiel14Asmaa Ibrahem Desouky Mostafa Ibrahem15Mohamed Fouad Elsayed Khalil16Neurology Department, faculty of medicine, Kafr El-sheikh universityNeurology Department, faculty of medicine, Kafr El-sheikh universityNeurology Department, faculty of medicine, Al-Azhar universityNeurology Department, faculty of medicine, Tanta universityRadiology Department, faculty of medicine, ELminia universityMedicine Department, College of Medicine, Taibah UniversityNeurology Department, Saudi German hospitalNeurology Department, Burjeel medical city Abu DhabiNeurology Department, Burjeel Royal Hospital Al AinNeurology Department, Faculty of medicine Zagazig universityNeurology Department, Faculty of medicine Zagazig universityNeurology department, faculty of medicine, Ain shams universityNeurology department, faculty of medicine, Ain shams universityDivision of neurology, department of medicine, University of AlbertaNeurology Department, El-Sahel Teaching hospitalNeurology Department Al-Raml HospitalNeurology Department, Saudi German hospital MadinahAbstract Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. Most studies evaluated the post-alteplase haemorrhagic transformation of brain infarction as a homogeneous entity but we evaluated the predictors of each subtype of haemorrhagic transformation of brain infarction. Our trial included 616 AIS alteplase-treated patients. We evaluated the ability of different risk factors, clinical presentation, and imaging features to predict different haemorrhagic transformation (HT) subtypes. HT was seen in 152 patients (24.7%), higher NIHSS, cardioembolic stroke and atrial fibrillation were independent predictors of all ECASS-based subtypes of hemorrhagic infarction, in addition, anterior-circulation stroke was an independent predictor of hemorrhagic infarction type 1 (odds ratio [OR], 11.04; 95% CI, 9.81 to 12.70; P-value > 0.001) and type2 (OR, 11.89; 95% CI, 9.79 to 14.44; P-value > 0.001), while older age was also an independent predictor of parenchymal hematoma type1 (OR, 1.312; 95% CI, 1.245 to 1.912; P-value 0.02). In AIS patients treated with alteplase in Egypt and Saudi Arabia, higher NIHSS, cardioembolic stroke and atrial fibrillation were independent predictors of all ECASS-based subtypes of hemorrhagic infarction; in addition, anterior-circulation stroke was an independent predictor of hemorrhagic infarction type 1 and 2, while older age was also an independent predictor of parenchymal hematoma type1. Trial registration: (clinicaltrials.gov NCT06337175), retrospectively registered on 29/03/2024.https://doi.org/10.1038/s41598-024-76189-0AlteplaseHemorrhagic infarctionEgyptSaudi ArabiaMiddle east
spellingShingle Mohamed G. Zeinhom
Sherihan Rezk Ahmed
Ahmed Mohamed Kohail
Islam Fathallah Mohamed Kamel
ALshimaa Mahfouz Abdelrahman
Omar M. AL-Nozha
Mohamed Almoataz
Tarek Youssif Omar Youssif
Ahmed Mohamed Ali Daabis
Hossam Mohamed Refat
Ahmed Ahmed Mohamed Kamal Ebied
Ahmed Elbassiouny
Ahmed Zaki Omar Akl
Ashfaq Shuaib
Mohamed Ismaiel
Asmaa Ibrahem Desouky Mostafa Ibrahem
Mohamed Fouad Elsayed Khalil
A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
Scientific Reports
Alteplase
Hemorrhagic infarction
Egypt
Saudi Arabia
Middle east
title A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
title_full A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
title_fullStr A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
title_full_unstemmed A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
title_short A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
title_sort multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis
topic Alteplase
Hemorrhagic infarction
Egypt
Saudi Arabia
Middle east
url https://doi.org/10.1038/s41598-024-76189-0
work_keys_str_mv AT mohamedgzeinhom amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT sherihanrezkahmed amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedmohamedkohail amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT islamfathallahmohamedkamel amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT alshimaamahfouzabdelrahman amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT omarmalnozha amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedalmoataz amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT tarekyoussifomaryoussif amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedmohamedalidaabis amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT hossammohamedrefat amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedahmedmohamedkamalebied amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedelbassiouny amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedzakiomarakl amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ashfaqshuaib amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedismaiel amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT asmaaibrahemdesoukymostafaibrahem amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedfouadelsayedkhalil amulticentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedgzeinhom multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT sherihanrezkahmed multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedmohamedkohail multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT islamfathallahmohamedkamel multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT alshimaamahfouzabdelrahman multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT omarmalnozha multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedalmoataz multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT tarekyoussifomaryoussif multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedmohamedalidaabis multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT hossammohamedrefat multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedahmedmohamedkamalebied multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedelbassiouny multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ahmedzakiomarakl multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT ashfaqshuaib multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedismaiel multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT asmaaibrahemdesoukymostafaibrahem multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis
AT mohamedfouadelsayedkhalil multicentertrialonthepredictorsofdifferentsubtypesofhemorrhagicinfarctionafterthrombolysis